|Text of Recommendation|| |
Rec. 2.c.1: The DoD OIG recommended that the Director of the Defense Health Agency create a chartered work group to meet at least quarterly to assess risks to the pharmaceutical supply chain and identify the pharmaceuticals most critical to beneficiary care at DoD Military Medical Treatment Facilities that are affected by those risks.
|Recommendation Number|| |
|Recommendation Status|| |
|Significant Recommendation|| |
|Recommendation Questioned Costs|| |
|Recommendation Funds for Better Use|| |